Key facts
- Notable investors include Draper Associates, Utrechtinc.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Eightsix Science
- ·The full record, as it builds
Funding rounds
No funding rounds for Eightsix Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eightsix Science
Developer of biohybrid neural grafts intended for longevity and lifespan extension. The company uses bioprinting and four-dimensional printing to create living neural tissue fused with tiny electronics, enabling the replacement of aging brain sections to maintain function and consciousness, to achieve biological independence and brain connection for lifespan extension.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2024
- Website
- eightsix.science/
- Ownership
- Privately Held (backing)
Eightsix Science doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eightsix Science shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eightsix Science in its N-PORT filings yet. We sweep new filings monthly.